184 related articles for article (PubMed ID: 37510689)
1. Safety and Healthcare Resource Utilization in Patients Undergoing Left Atrial Appendage Closure-A Nationwide Analysis.
Thevathasan T; Degbeon S; Paul J; Wendelburg DK; Füreder L; Gaul AL; Scheitz JF; Stadler G; Rroku A; Lech S; Buspavanich P; Huemer M; Attanasio P; Nagel P; Reinthaler M; Landmesser U; Skurk C
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510689
[TBL] [Abstract][Full Text] [Related]
2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
3. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
[TBL] [Abstract][Full Text] [Related]
4. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
5. Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data.
Vuddanda VLK; Turagam MK; Umale NA; Shah Z; Lakkireddy DR; Bartus K; McCausland FR; Velagapudi P; Mansour M; Heist EK
Heart Rhythm; 2020 Mar; 17(3):374-382. PubMed ID: 31539630
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
[TBL] [Abstract][Full Text] [Related]
7. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
8. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
[TBL] [Abstract][Full Text] [Related]
9. The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).
Wang Y; Wu D; Ma J; Liu X; Zhang H; So CY; Lam YY; Wang B; Wang J; Zhang H; Wang M; Song G; Wu Y
Am J Cardiovasc Dis; 2021; 11(5):679-687. PubMed ID: 34849300
[TBL] [Abstract][Full Text] [Related]
10. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
Badheka AO; Chothani A; Mehta K; Patel NJ; Deshmukh A; Hoosien M; Shah N; Singh V; Grover P; Savani GT; Panaich SS; Rathod A; Patel N; Arora S; Bhalara V; Coffey JO; O'Neill W; Makkar R; Grines CL; Schreiber T; Di Biase L; Natale A; Viles-Gonzalez JF
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):42-8. PubMed ID: 25480543
[TBL] [Abstract][Full Text] [Related]
11. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
[TBL] [Abstract][Full Text] [Related]
13. Short-Term Outcomes Following Left Atrial Appendage Closure in the Very Elderly: A Population-Based Analysis.
Farwati M; Amin M; Isogai T; Saad AM; Abushouk AI; Krishnaswamy A; Wazni O; Kapadia SR
J Am Heart Assoc; 2022 Aug; 11(16):e024574. PubMed ID: 35929467
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in the Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
Abusnina W; Latif A; Al-Abdouh A; Mostafa MR; Radaideh Q; Alshebani Y; Aboeata A; Ben-Dor I; Michos ED; Dahal K
Cardiovasc Revasc Med; 2022 Aug; 41():29-34. PubMed ID: 34952822
[TBL] [Abstract][Full Text] [Related]
15. Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
Nazir S; Ahuja KR; Ariss RW; Hassanein M; Schurmann P; Koneru S; Afshar H; Giorgberidze I; Moukarbel GV; Jneid H
Catheter Cardiovasc Interv; 2021 Nov; 98(6):E839-E846. PubMed ID: 33856101
[TBL] [Abstract][Full Text] [Related]
16. Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies.
Brouwer TF; Whang W; Kuroki K; Halperin JL; Reddy VY
J Am Heart Assoc; 2019 Dec; 8(23):e013525. PubMed ID: 31752643
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
[TBL] [Abstract][Full Text] [Related]
18. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
[TBL] [Abstract][Full Text] [Related]
19. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in the Combined Ablation and Left Atrial Appendage Closure: Results From LAACablation Registry.
Chen M; Sun J; Li W; Zhang PP; Zhang R; Mo BF; Yang M; Wang QS; Li YG
JACC Asia; 2023 Feb; 3(1):138-149. PubMed ID: 36873751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
